Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while reducing the diagnostic interference of vaccine antibodies
Loading...
Date
2024-11-09
Authors
López Fernández, NereaAndrés Barranco, Sara
Miguel López, María Jesús de
Salvador Bescós, M.
Zúñiga Ripa, Amaia
Iriarte, Maite
Blasco Martínez, José María
Moriyón Uria, Ignacio
Conde Álvarez, Raquel
Muñoz Álvaro, Pilar María
Journal Title
Journal ISSN
Volume Title
Publisher
Typology
póster no publicado en actas de congresoAbstract
AIM OF THIS WORK: To evaluate the use of the conjunctival route as a strategy to reduce the persistence of H38ΔwbkF vaccine antibodies while maintaining protection against B. ovis.
Description
Keywords
Bibliographic citation
López-Fernández, N., Andrés-Barranco, S., De Miguel, M. J., Salvador-Bescós, M., Zúñiga-Ripa, A., Iriarte, M., Blasco, J. M., Moriyón, I., Conde-Álvarez, R., & Muñoz, P. M. (2025). Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while reducing the diagnostic interference of vaccine antibodies [Póster]. En: International Veterinary Vaccinology Network Conference 2024 (Ho Chi Minh City. Vietnam. 2024)
AGROVOC subjects
Brucella ovisVacuna
Brucella melitensis
Sponsorship
Research supported by MCIN/AEI (projects PID2023-146797OB-C31, PID2023-146797OB-C32, PID2019-107601RB-C31 and PID2019107601RA-C32), Aragón Goverment (A23-21R) and REPRODIVAC / Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact from the EU Horizon research and innovation program under Grant Agreement No. 101060313. Acknowledgements: Sara Serrano for her excellent technical assistant.